Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (2745)	10/23/2000 12:38:02 PM
From: Eric Fader	Read Replies (1) \| Respond to of 5582

Oooh, look, everybody. Someone showed Stevie how to use the "MKAC" function on his Bloomberg. What he's not telling everyone is that GNLN's percentage of GUMM's trading volume was MUCH higher in past months. In particular (and I'm doing this from memory since I'm not at the terminal, so I may be off a little on the numbers), in the pre-Zicam era, GNLN supported the stock by controlling half the float in the 8-11 price range, and their accounts sold a lot of it on the way up to the 30's. Does buying up all they could under 10 sound like a bad move to anyone right now?? <LOL> It's not at all unusual for a small house, like GNLN, or maybe Penn Merchants Group or Advest, to take an almost paternal interest in a little stock it believes in, and there's nothing wrong with GunnAllen as a firm. After all, we're not talking about Ray Dirks, TRAV or WDCO here. It's just more intentional effluvium from the undisputed master of message-board flatulence.